Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 11,500 readers every working day
  • Great reaction with click through rates of up to 6.5%
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

Special Report
Digital transformation in pharma - what's it look like?
If digital is the future for pharma businesses then getting there will call for change from the top down writes Tania Rowland.
Approvals Action
Baxalta registers new haemophilia treatment
Shire-owned Baxalta has won TGA approval for a new haemophilia A treatment under the brand name Adynovate.
Pipeline Monitor
First Parkinson's drug in a decade wins US tick
Parkinson's disease patients now have something to turn to in the 'off' period when their standard medication loses effectiveness.
Debating Point
Resources in question as TGA modernises
Most areas of the pharmaceutical sector appear to agree that modernising the TGA is a good thing but how much pressure the new requirements will place on the regulator's resources remains an issue.